Emerging Bismuth Chalcogenides Based Nanodrugs for Cancer Radiotherapy

Abstract

Radiotherapy (RT), as one of the main methods of clinical tumor treatment, has been applied to the treatment of most solid tumors. However, the effect of RT is compromised by the radiation resistance of tumor hypoxic environment and non-specific damage caused by high-dose radiation. Bismuth chalcogenides (Bi2X3, X = S, Se) based nanodrugs have attracted widespread attention as highly efficient radiosensitizers due to their high photoelectric effect and excellent biocompatibility. More importantly, specially designed nanocomposites can effectively alleviate the radiation resistance of tumor tissues. Here, for the first time, we systematically summarize the latest progresses of Bi2X3 nanodrugs to enhance RT by alleviating the hypoxic tumor microenvironment. These emerging Bi2X3 nanodrugs mainly include three aspects, which are Bi2X3 nanocomposites with high-efficient O2 supply, non-O2-dependent Bi2X3 nanocomposites RT enhancers, and Bi2X3 nanocomposites-based photothermal-enhanced radiosensitizers. These Bi2X3 nanodrugs can effectively overcome the RT resistance of tumor hypoxic microenvironment, and have extremely high therapeutic effects and clinical application prospects. Finally, we put forward the challenges and prospects of Bi2X3 nanomaterials in the field of RT.

Nucleus-Targeting Phototherapy Nanodrugs for High-Effective Anti-Cancer Treatment

“…Hf-HI-4COOH achieved effective tumor-killing effects while avoiding damage to the skin and normal organs under low power density (0.3 W/cm 2 ) laser irradiation due to their high photothermal conversion efficiency and the intrinsic nucleus-targeting property. The tumor extracellular space is slightly acidic (pH = 6.5–6.8) because the tumor microenvironment is rich in lactate ( Zhen et al, 2021 ; Huang et al, 2022 ; Zhu et al, 2022 ). To further improve the targeting of cancer therapy, Phuong et al (2020) developed a slightly acidic environment-responsive carbon dot/TiO 2 nanocomposites for nucleus-targeting PTT.…”

Smart Nanoparticles for Breast Cancer Treatment Based on the Tumor Microenvironment

“…Compared with normal tissue, the tumor tissue has a higher temperature, which makes it possible to control and release drugs by external heating at the tumor site, and this property has been exploited in the development of smart drug delivery systems (SDDSs) targeting tumors (74,(78)(79)(80)(81)(82). Ding et al (79) designed a multifunctional SDDS with a double-layer structure: a thermosensitive copolymer as the building block of the core-shell structure, two chemotherapeutic drugs [paclitaxel (PTX) and DOX; NP-PD) were encapsulated to form copolymers, and the siRNA (NP-PD-S) affecting survival was absorbed on the surface to form nanostructures, which were finally wrapped by selfpolymerizing dopamine (PDA) membranes (NP-PD-S-PDA).…”

Nanodrugs Detonate Lysosome Bombs

“…The battle against tumors has been ongoing for decades, and a multitude of anticancer drugs have been developed. Many antitumor therapeutic strategies rely on the activation of the apoptosis pathway in tumor cells ( Kolenko et al, 2000 ; Huang et al, 2022 ), a signaling cascade involving caspases leading to apoptosis (also known as caspase-dependent cell death). However, tumor cells are resistant to apoptosis-inducing and caspase-activating drugs by mutating pro-apoptotic proteins and overexpressing anti-apoptotic proteins ( Giampazolias et al, 2017 ).…”